BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 20195363)

  • 1. The octarepeat region of the prion protein is conformationally altered in PrP(Sc).
    Yam AY; Gao CM; Wang X; Wu P; Peretz D
    PLoS One; 2010 Feb; 5(2):e9316. PubMed ID: 20195363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The number of octapeptide repeat affects the expression and conversion of prion protein.
    Hiraga C; Kobayashi A; Kitamoto T
    Biochem Biophys Res Commun; 2009 May; 382(4):715-9. PubMed ID: 19318088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing misfolding of the prion protein by trimethylamine N-oxide.
    Bennion BJ; DeMarco ML; Daggett V
    Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prion protein and copper: a mysterious relationship].
    Rachidi W; Riondel J; McMahon HM; Favier A
    Pathol Biol (Paris); 2005 May; 53(4):244-50. PubMed ID: 15850959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Octapeptide repeat region of prion protein (PrP) is required at an early stage for production of abnormal prion protein in PrP-deficient neuronal cell line.
    Sakudo A; Wu G; Onodera T; Ikuta K
    Biochem Biophys Res Commun; 2008 Jan; 365(1):164-9. PubMed ID: 17981146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histidines in the octapeptide repeat of PrPC react with PrPSc at an acidic pH.
    Cruite JT; Abalos GC; Bellon A; Solforosi L
    Biochemistry; 2011 Mar; 50(10):1618-23. PubMed ID: 21268659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of rafts in the fibrillization and aggregation of prions.
    Pinheiro TJ
    Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
    Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
    Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expansion of the octarepeat domain alters the misfolding pathway but not the folding pathway of the prion protein.
    Leliveld SR; Stitz L; Korth C
    Biochemistry; 2008 Jun; 47(23):6267-78. PubMed ID: 18473442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-dimensional mapping of three phenotype-associated isoforms of the prion protein in sporadic Creutzfeldt-Jakob disease.
    Zanusso G; Righetti PG; Ferrari S; Terrin L; Farinazzo A; Cardone F; Pocchiari M; Rizzuto N; Monaco S
    Electrophoresis; 2002 Jan; 23(2):347-55. PubMed ID: 11840543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classification of sporadic Creutzfeldt-Jakob disease revisited.
    Cali I; Castellani R; Yuan J; Al-Shekhlee A; Cohen ML; Xiao X; Moleres FJ; Parchi P; Zou WQ; Gambetti P
    Brain; 2006 Sep; 129(Pt 9):2266-77. PubMed ID: 16923954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creutzfeldt-Jakob disease and inclusion body myositis: abundant disease-associated prion protein in muscle.
    Kovacs GG; Lindeck-Pozza E; Chimelli L; Araújo AQ; Gabbai AA; Ströbel T; Glatzel M; Aguzzi A; Budka H
    Ann Neurol; 2004 Jan; 55(1):121-5. PubMed ID: 14705121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
    Sasaki K; Minaki H; Iwaki T
    J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of monoclonal antibody that distinguishes PrPSc from PrPC and neutralizes prion infectivity.
    Horiuchi M; Karino A; Furuoka H; Ishiguro N; Kimura K; Shinagawa M
    Virology; 2009 Nov; 394(2):200-7. PubMed ID: 19766283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PrP(Sc) of scrapie 263K propagates efficiently in spleen and muscle tissues with protein misfolding cyclic amplification.
    Shi S; Dong CF; Wang GR; Wang X; An R; Chen JM; Shan B; Zhang BY; Xu K; Shi Q; Tian C; Gao C; Han J; Dong XP
    Virus Res; 2009 Apr; 141(1):26-33. PubMed ID: 19162101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential solubility of prions is associated in manifold phenotypes.
    Kuczius T; Karch H; Groschup MH
    Mol Cell Neurosci; 2009 Nov; 42(3):226-33. PubMed ID: 19607920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methionine sulfoxides on PrPSc: a prion-specific covalent signature.
    Canello T; Engelstein R; Moshel O; Xanthopoulos K; Juanes ME; Langeveld J; Sklaviadis T; Gasset M; Gabizon R
    Biochemistry; 2008 Aug; 47(34):8866-73. PubMed ID: 18680312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoreactivity enhancement with chelators for increasing the detection sensitivity of human PrPSc by Western blotting.
    Kuczius T; Brinkmann B; Grassi J
    Neurochem Int; 2007 Jan; 50(1):102-8. PubMed ID: 16962685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of prion protein (PrP)-derived peptides that discriminate full-length PrPSc from PrPC.
    Lau AL; Yam AY; Michelitsch MM; Wang X; Gao C; Goodson RJ; Shimizu R; Timoteo G; Hall J; Medina-Selby A; Coit D; McCoin C; Phelps B; Wu P; Hu C; Chien D; Peretz D
    Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11551-6. PubMed ID: 17601775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Truncated PrP(c) in mammalian brain: interspecies variation and location in membrane rafts.
    Laffont-Proust I; Hässig R; Haïk S; Simon S; Grassi J; Fonta C; Faucheux BA; Moya KL
    Biol Chem; 2006 Mar; 387(3):297-300. PubMed ID: 16542151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.